Specific trials or examination exists in detecting deadly diseases. Various facilities are provided these days for determining many chronic diseases, like in detecting cancer, tuberculosis, keratin level (dialysis), coronary artery disease, etc. But delaying in diagnosing emerg...
Open access
Research Article10.9734/jpri/2021/v33i19A31331
Background: In December 2019 Chinese higher officials have acknowledged a number of cases of pneumonia happened in Wuhan, China with those patients who used the seafood from market selling live animals. At the end of December 2019, a kind of new pneumonia feast quickly in Wuhan,...
Open access
Research Article10.9734/jpri/2021/v33i19B31339
As a developing nation and the most populous nation in Africa, Nigeria has faced challenges associated with meeting the food needs of its expanding population over the years. This is due to the nation transitioning from a net exporter of foods to being dependent on food imports,...
Open access
Research Article10.9734/ejnfs/2021/v13i230380
COVID-19 was announced as a global pandemic on 11 March 2020 by the World Health Organization due to its spread globally. Nigeria recorded its first case on 27 February 2020. Since then, it has spread to all parts of the country. In this paper we study the effectiveness and skil...
Open access
Research Article10.9734/ajrcos/2021/v7i330182
The long-existing prevalence of maladaptive behaviors, particularly tobacco consumption and smoking continue to be a public health concern in rural India. The COVID-19 pandemic has engendered a state of prolonged home-confinement and social isolation across the globe. The bio-psy...
Coronavirus Disease 2019 (COVID-19) was first reported in December 2019, in the City of Wuhan, China. Within the span of a few weeks, the disease had spread to other regions of China and eventually to different parts of the world. COVID 19 has affected 221 countries and territori...
Open access
Research Article10.9734/jpri/2021/v33i1731309
Background: This paper adopted scientific approach to validate the WHO/NCDC safety counseling guidelines to prevent the spread of the SARS-COV 2 coronaviruses in Nigeria in the guidance and counseling perspectives using the sequence characteristics of SARS-COV 2 in Nigeria as val...
Open access
Research Article10.9734/arrb/2021/v36i230342
This research is based on the policy given by central and local governments to stop the face-to-face learning process during the COVID-19 pandemic. It is due to prevent the coronavirus contagion spread and in exchange, remote learning is conducted by utilizing internet as one of...
Open access
Research Article10.9734/ajeba/2021/v21i430369
Novel corona virus 2019 also known as severe acute respiratory syndrome coronavirus 2 [SARS COV2] is enveloped non segmented ribonucleic acid (RNA) virus. Acute ischemic stroke remains emergency during covid19 pandemic [1] Here we present a case of a woman with COVID 19 who prese...
Open access
Research Article10.9734/ajrid/2021/v6i330194
Aims: The variability in evolution of the novel coronavirus has perplexed the medical community. We herein report the case of a patient with specific characteristics, somewhat outside the reported average values. Presentation of Case: A 60-year-old type I diabetic patient was adm...
Open access
Research Article10.9734/jammr/2021/v33i630865
We construct a simple mathematical model that describes the dynamics of the transmission of COVID-19 disease in a human population. It accounts for the various phases of the disease and its mode of contact through infectious humans and surfaces. The contribution of asymptomatic h...
Open access
Research Article10.9734/arjom/2021/v17i130269
A. D’Alessio, M. Cottini, C. Lombardi, M. Uccelli, F. Bracchi, G. Cesana, D. Di Mauro, A. Fargnoli, C. Giussani, F. Martini, M. Motta, S. Olmi, N. Sertori, M. Taverna & P. Del Poggio·Asian Journal of Medicine and Health·2021
Background: Hydroxychloroquine (HCQ) has been used against SARS-CoV-2, but large non randomized studies failed to show any clinical benefit. However, in these studies the drug was started in the hospital setting, a significant time after the onset of symptoms. Aim of the Study: t...
Open access
Research Article10.9734/ajmah/2021/v19i230301
Daniele Melo Sardinha, Karla Valéria Batista Lima, Thalyta Mariany Rêgo Lopes Ueno, Yan Corrêa Rodrigues, Juliana Conceição Dias Garcez, Anderson Lineu Siqueira dos Santos, Ana Lúcia da Silva Ferreira, Ricardo José de Paula Souza e Guimarães & Luana Nepomuceno Gondim Costa Lima·Journal of Pharmaceutical Research International·2021
Cardiovascular Diseases represent the main cause of death in the world, and are associated with risk factors that cause serious complications in cases of infections, such as those of the respiratory tract. In March 2020 the World Health Organization declared a pandemic for SARS-C...
Open access
Research Article10.9734/jpri/2021/v33i1431270
Background: IgG antibodies may serve as promising targets to detect and evaluate immune responses against the SARS-CoV-2 virus. Both IgA and IgM antibodies target the spike protein’s receptor binding domain and are rapidly decayed, while IgG antibodies remain relatively stable fo...
Open access
Research Article10.9734/jamb/2021/v21i230323
All the countries in the world are struggling to improve their healthcare systems regardless of being rich or poor. Talking about Cuba, it represents an example of well-developed healthcare system and policies which is comparable to developed countries of the world. The success o...
Open access
Research Article10.9734/ajmah/2021/v19i130298